BD announces leadership changes
Tuesday 18 November 2008 Girija Shettar - Senior Reporter, World Markets
Becton Dickinson (Franklin Lakes, New Jersey) has promoted Vincent Forlenza (pictured) to president, effective from January 2009; and David Elkins is named as executive vice-president and CFO, effective from December 1 2008.
Former president Edward Ludwig will remain as CEO and chairman; former executive vice-president Gary Cohen, and former CFO John Considine will join the Office of the CEO – a special strategic group for the CEO.
Mr Considine will continue to be responsible for: integrated supply chain; IT; environment; health and safety; project management and engineering services; and security.
Mr Forlenza, who has been with the company since 1980, most recently as executive vice-president and the head of BD Diagnostics, will oversee the medical, diagnostics and biosciences divisions, international and quality operations.
Mr Elkins will be responsible for executive management and oversight of the company’s global financial operations. He joins from AstraZeneca, where in 2006 he became vice-president and CFO for North America and global marketing.
Related News
Comments
No Comments Yet
Clinica Delivers:
- Daily email of hand picked industry critical news and developments
- 25 feature-packed issues a year in print or as PDF - both with FREE online access
- Exclusive features such as Medtech ventures and New Stock Tracker
- A fully-searchable archive of issues and articles dating back to 1995.



